Gaku Yamamichi

Suita, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.

Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.

Journal: Biomarker research
Published: April 29, 2026

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Journal: Scientific reports
Published: April 02, 2026

Role of Latrophilin-1 and Latrophilin-2 as Downstream Effectors of Androgen Receptor Signaling in Urothelial Tumorigenesis.

Role of Latrophilin-1 and Latrophilin-2 as Downstream Effectors of Androgen Receptor Signaling in Urothelial Tumorigenesis.

Journal: Cancer reports (Hoboken, N.J.)
Published: January 30, 2026

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

Journal: Anticancer research
Published: December 02, 2025

Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.

Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.

Journal: Chinese clinical oncology
Published: November 25, 2025

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Journal: BJUI compass
Published: October 16, 2025

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Journal: Cancer science
Published: August 13, 2025

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.

Journal: Cancer science
Published: April 01, 2025

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Journal: Anticancer research
Published: December 20, 2024

Evaluation of the diagnostic concordance of FDA-approved PD-L1 assays in clear cell renal cell carcinoma.

Evaluation of the diagnostic concordance of FDA-approved PD-L1 assays in clear cell renal cell carcinoma.

Journal: Scientific reports
Published: October 14, 2024

FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma.

FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma.

Journal: Scientific reports
Published: September 28, 2024

Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.

Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.

Journal: Biochemical and biophysical research communications
Published: September 09, 2024
Showing 1-12 of 59

Last Updated: 09/26/2026